SEC Form 3 · accession 0001104659-26-080804
Liminatus Pharma, Inc. · LIMN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ewon Comfortech Co., Ltd.
10% Owner
Period of report
Jun 24, 2026
Accepted (ET)
Jul 6, 2026 · 4:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001971387
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per shareF1 | holding | — | — | — | 5,500,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Consists of 5,500,000 shares of common stock held of record by Ewon Comfortech Co. Ltd ("Ewon"), which includes 4,373,603 shares transferred from Valetudo Therapeutics LLC ("Valetudo") to Ewon on June 24, 2026, which shares Valetudo retains voting power over pursuant to a voting agreement.